SLC6A3 and Alzheimer disease: A recent study from Mesulam et al. [28] showed supportive results, where PPA-AD patients demonstrated preserved memory functioning years into the disease course, despite hippocampo-entorhinal AD neuropathology comparable to that of DAT-AD.